Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial
COMET
Vaginal Surgery for the Pelvic Floor: A Randomized Trial of Synthetic Mesh Versus Synthetic Sutures
1 other identifier
interventional
358
1 country
1
Brief Summary
This is a Canadian, multi-centre, double-blind randomized controlled trial of an innovative vaginal surgery technique for correction of pelvic organ prolapse (POP) in women. Vaginal surgery is preferred as minimally invasive, however the investigators do not know if materials such as synthetic polypropylene mesh improve success, durability and cost-effectiveness long-term. The investigators principal goal is to compare the experimental bilateral sacrospinous vaginal vault fixation with synthetic mesh arms (BSSVF-M) to the current standard of sacrospinous ligament suspension with synthetic sutures (SSLS) over a timeline of 2 years. Patients and evaluators will be blind to technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 8, 2016
CompletedFirst Posted
Study publicly available on registry
November 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
May 1, 2026
April 1, 2026
10 years
November 8, 2016
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Composite outcome of 3 objective signs and 1 subjective symptom of POP (yes/no answers). The definition of surgical success, used in the OPTIMAL trial as described in the description below.
The Optimal Trial Outcome is the absence of all the following: (1) objectively recorded, via POP quantification (POP-Q)15, recurrent POP of the top of the vagina beyond the upper third of the vaginal canal; (2) objectively recorded, via POPQ, recurrent POP of the anterior or posterior vaginal walls beyond the hymenal ring (vaginal entrance); (3) vaginal bulge symptoms reported by the patient, as indicated by an affirmative response to either: "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?" and any response other than "not at all" to the question "How much does that bother you?" (4) re-treatment for prolapse by either surgery or pessary (conservative treatment with insertion of a silicone ring in the vagina for support). The POPQ is a validated quantification system with adequate interrater reliability which measures, in centimeters, the extent of vaginal wall descent with respect to a reference point at the hymenal ring.
2 years postoperatively
Secondary Outcomes (12)
Change in maximal POP of vaginal compartments via POPQ, obtained by research personnel (nurse or clinical fellow) trained in POPQ and blinded to group allocation. POP will be quantified and compared to baseline.
Baseline to 6 weeks,12 and 24 months
Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: Pelvic Floor Distress Inventory (PFDI-20)
Baseline to 6 weeks,12 and 24 months
Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: Pelvic Floor Impact Questionnaire (PFIQ-7)
Baseline to 6 weeks, 12 and 24 months
Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: the short form McGill pain questionnaire
Baseline to 6 weeks, 12 and 24 months
Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: the a validated gender-specific body image scale specifically for POP (BIPOP) Questionnaire
Baseline to 6 weeks, 12 and 24 months
- +7 more secondary outcomes
Other Outcomes (1)
Health economic evaluation
6 weeks, 6, 12 and 24 months postoperatively
Study Arms (2)
SSLS Procedure
ACTIVE COMPARATORBSSVF-M Procedure
ACTIVE COMPARATORInterventions
Bilateral sacrospinous vaginal vault fixation with synthetic mesh arms
Eligibility Criteria
You may qualify if:
- Women over 19 years of age
- Able to read and write in English
- Able to follow up with clinic visits for up to two years after surgery
- Diagnosed with bothersome pelvic organ prolapse including at the top of the vagina
You may not qualify if:
- Women who wish to conserve the uterus
- Prior pelvic radiation
- Prior vaginal mesh surgery for prolapse
- Prior vaginal mesh exposure
- Presence of vaginal pain from pelvic floor muscle spasm documented at baseline visit
- Immune compromise; chronic steroid use
- Current smoker
- Currently pregnant or breastfeeding
- Presence of pain syndromes likely to cause a heightened sensitivity to pelvic pain (IE fibromyalgia or painful bladder syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre for Advancing Health Outcomescollaborator
- University of British Columbialead
- University of Albertacollaborator
- McGill Universitycollaborator
- McMaster Universitycollaborator
Study Sites (1)
St. Paul's Hospital
Vancouver, British Columbia, V6Z 2K5, Canada
Related Publications (1)
Roa L, Larouche M, Hyakutake M, Brennand EA, Malabarey O, Koenig N, Lee T, Singer J, Zhang W, Brotto LA, Geoffrion R. COMET (Composite Outcomes of Mesh vs suture Techniques for prolapse repair)- Protocol for a single blind randomized controlled multicenter trial testing surgical innovation in female pelvic surgery. PLoS One. 2024 Oct 24;19(10):e0308926. doi: 10.1371/journal.pone.0308926. eCollection 2024.
PMID: 39446736DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Roxana Geoffrion
Study Record Dates
First Submitted
November 8, 2016
First Posted
November 16, 2016
Study Start
November 1, 2016
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04